Amgen Earnings beat, Revenue misses In Q4

  • Investing.com
  • Stock Market News
Amgen Earnings beat, Revenue misses In Q4
Credit: © Reuters.

Investing.com - Amgen (NASDAQ: AMGN ) reported on Monday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

Amgen announced earnings per share of $4.36 on revenue of $6.85B. Analysts polled by Investing.com anticipated EPS of $4.07 on revenue of $6.88B.

Amgen shares are down 0% from the beginning of the year and are trading at $224.70 , down-from-52-week-high.They are outperforming the Nasdaq 100 which is down 10.72% from the start of the year.

Amgen shares gained 0.52% in after-hours trade the report.

Amgen follows other major Healthcare sector earnings this month

Amgen's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.

J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100